Parker

发表

The Study of Haze Formation in Freshly Packaged and Stored Beers

Parker, Parker, 2007 .

Investigation on a novel and specific leukotriene B4 receptor antagonist in the treatment of stable plaque psoriasis

Parker, Van De Kerkhof, D. Jong, 1998, The British journal of dermatology.

‘Low‐risk’ myelodysplastic syndrome is associated with excessive apoptosis and an increased ratio of pro‐ versus anti‐apoptotic bcl‐2‐related proteins

Parker, A. Pagliuca, Pagliuca, 1998, British journal of haematology.

Neoadjuvant chemotherapy for locally advanced cervical cancer: a systematic review and meta-analysis of individual patient data from 21 randomised trials.

Parker, L. Stewart, M. Tattersall, 2003, European journal of cancer.

Atlogencic bone marrow transplantation for secondary leukaemia and myelodysplastic syndromes: a survey by the Leukaemia Work ing Party of the European Bone Marrow Transplantation Group

Parker, M. Dekker, O. Donnell, 2017 .

DNA vaccines for cancer therapy.

Parker, M. Wloch, Norman, 1999, Expert opinion on investigational drugs.

B-cell lymphocytosis survival in early stage chronic lymphocytic leukemia and monoclonal Low frequency mutations independently predict poor treatment free

Parker, D. Oscier, M. Rose-Zerilli, 2015 .

Ineffective haemopoiesis and apoptosis in myelodysplastic syndromes

Parker, Mufti, 1998, British journal of haematology.

An expert consensus to standardize definitions , diagnosis and treatment targets for anti-fibrotic stricture therapies in Crohn ’ s disease SHORT TITLE : Novel anti-fibrotics for Crohn ’ s disease

Parker, J. Fletcher, J. Stoker, 2018 .

Neoadjuvant chemotherapy for locally advanced cervical cancer: a systematic review and meta-analysis of individual patient data from 21 randomised trials

Parker, L. Stewart, M. Tattersall, 2003 .

Title: the Neoadjuvant Model Is Still the Future for Drug Development in Breast Cancer Statement of Translational Relevance

Parker, D. Berry, E. Petricoin, 2015 .

Title : A randomised assessment of image guided radiotherapy within a phase 3 trial of Conventional or Hypofractionated High Dose Intensity Modulated Radiotherapy for Prostate Cancer ( CHHiP )

Parker, D. Dearnaley, V. Khoo, 2018 .